Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TVTX | AZN | AMGN | GILD | BMY |
| Company | Travere Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 39.83 | 201.44 | 346.63 | 138.61 | 57.67 |
| High | 40.00 | 201.80 | 351.25 | 140.26 | 58.98 |
| Low | 38.12 | 199.99 | 346.60 | 137.75 | 57.66 |
| Latest | 39.54 | 200.47 | 349.39 | 138.55 | 58.96 |
| Change | -1.41 | -0.74 | +1.17 | -1.22 | +1.07 |
| % Change | -3.44% | -0.37% | +0.34% | -0.87% | +1.85% |
| Volume | 4,562,000 | 1,414,400 | 1,981,700 | 3,432,500 | 8,220,601 |
| 20-Day Average Volume | 2,602,615 | 1,923,475 | 2,740,555 | 5,893,020 | 12,882,005 |
| Previous Close | 40.95 | 201.21 | 348.22 | 139.77 | 57.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.00 | 196.09 | 349.56 | 138.91 | 58.79 |
| 20-Day Raw Stochastic | 78.03% | 72.58% | 58.77% | 51.32% | 43.46% |
| 20-Day Relative Strength | 65.73 | 54.15 | 46.34 | 46.43 | 50.30 |
| Weighted Alpha | +104.34 | +46.64 | +24.96 | +31.34 | +24.87 |
| Today's Opinion | 56% Buy | 88% Buy | 40% Buy | 40% Buy | 64% Buy |
| Previous Opinion | 56% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Last Month's Opinion | 24% Sell | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.76% since 04/09/26 | -2.20% since 04/09/26 | -1.75% since 04/09/26 | -2.49% since 04/09/26 | -0.86% since 04/09/26 |
| Low | 28.29 on 04/10/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 137.02 on 04/13/26 | 57.22 on 04/15/26 |
| High | 43.31 on 04/14/26 | 207.30 on 04/10/26 | 357.46 on 04/10/26 | 142.38 on 04/10/26 | 59.80 on 04/10/26 |
| 1-Month | |||||
| %Chg | +41.06% since 03/16/26 | +4.41% since 03/16/26 | -4.60% since 03/16/26 | -4.59% since 03/16/26 | -1.26% since 03/16/26 |
| Low | 26.15 on 03/20/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 43.31 on 04/14/26 | 207.30 on 04/10/26 | 368.78 on 03/17/26 | 146.71 on 03/17/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +41.87% since 01/16/26 | +6.19% since 01/16/26 | +5.74% since 01/16/26 | +10.92% since 01/16/26 | +6.70% since 01/16/26 |
| Low | 26.15 on 03/20/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 53.54 on 01/21/26 |
| High | 43.31 on 04/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +43.73% since 10/16/25 | +19.57% since 10/16/25 | +18.11% since 10/16/25 | +17.56% since 10/16/25 | +35.88% since 10/16/25 |
| Low | 22.59 on 01/13/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 43.31 on 04/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,652,310 | 310,910,528 | 188,560,544 | 171,971,328 | 120,380,688 |
| Shares Outstanding, K | 92,370 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 490,730,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -25,550,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 129,690,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 2,730,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.86 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.03 on 02/19/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/07/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.97 | 15.94 | 17.15 | 9.41 |